- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 41/00 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Patent holdings for IPC class A61P 41/00
Total number of patents in this class: 486
10-year publication summary
|
14
|
9
|
20
|
34
|
39
|
32
|
38
|
22
|
27
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ARC Medical Devices, Inc. | 15 |
8 |
| Omrix Biopharmaceuticals Ltd. | 153 |
8 |
| Toray Industries, Inc. | 6950 |
5 |
| Bioregen Biomedical (Changzhou) Co., Ltd. | 30 |
5 |
| The Governing Council of The University of Toronto, | 1474 |
5 |
| Nanotheta Co, Ltd. | 27 |
5 |
| Xigen Inflammation Ltd. | 27 |
5 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
4 |
| Terumo Kabushiki Kaisha | 5549 |
4 |
| CoDa Therapeutics, Inc. | 19 |
4 |
| Mochida Pharmaceutical Co., Ltd. | 338 |
4 |
| Novartis AG | 10744 |
3 |
| The Regents of the University of California | 19961 |
3 |
| Medtronic, Inc. | 9817 |
3 |
| President and Fellows of Harvard College | 5986 |
3 |
| Battelle Memorial Institute | 2492 |
3 |
| Mayo Foundation for Medical Education and Research | 3222 |
3 |
| Dainichiseika Color & Chemicals Mfg. Co., Ltd. | 371 |
3 |
| Farnex Incorporated | 13 |
3 |
| Hibernation Therapeutics Ltd | 4 |
3 |
| Other owners | 402 |